- Trials with a EudraCT protocol (44,380)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
44,380 result(s) found.
Displaying page 99 of 2,219.
| EudraCT Number: 2009-010811-34 | Sponsor Protocol Number: 113018 | Start Date*: 2009-04-16 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A Phase III, open, non-randomized, multi-centric, single dose study to assess mmunogenicity and safety of Fluarix / Influsplit SSW® 2009/2010 injected intramuscularly in young adults (18 to 60 year... | ||
| Medical condition: Immunization against influenza of healthy adults. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2009-010825-37 | Sponsor Protocol Number: CRFB002DES01 | Start Date*: 2009-06-29 | |||||||||||
| Sponsor Name:Novartis Farmaceutica S.A | |||||||||||||
| Full Title: Ensayo clínico de fase II, controlado, abierto, aleatorizado y multicéntrico, para comparar la eficacia y la seguridad de ranibizumab (inyección intravítrea) frente a fotocoagulación láser en pacie... | |||||||||||||
| Medical condition: Edema macular diabético | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-015883-32 | Sponsor Protocol Number: 28431754DIA3005 | Start Date*: 2010-02-18 | |||||||||||
| Sponsor Name:Janssen-Cilag International NV | |||||||||||||
| Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Canagliflozin as Monotherapy in the Treatment of Subjects Wit... | |||||||||||||
| Medical condition: Type 2 Diabetes Mellitus | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: LT (Completed) SE (Completed) ES (Completed) IS (Completed) EE (Completed) AT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2009-014944-13 | Sponsor Protocol Number: 242-08-210 | Start Date*: 2009-11-06 | |||||||||||
| Sponsor Name:Otsuka Pharmaceutical Development & Commercialization, Inc. | |||||||||||||
| Full Title: A Phase 2, Multi-center, Non-controlled, Open-label Dose Escalation Trial to Assess the Safety, Tolerability, Pharmacokinetics, and Efficacy of Orally Administered OPC-67683 Two Times Daily to Pati... | |||||||||||||
| Medical condition: Pulmonary Multidrug-resistant Tuberculosis | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: LV (Completed) LT (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-002362-66 | Sponsor Protocol Number: 111738 | Start Date*: 2008-09-03 |
| Sponsor Name:GlaxoSmithKline Biologicals | ||
| Full Title: A phase III, observer-blind, multi-country, multi-centre study to evaluate the safety, reactogenicity and immunogenicity of GlaxoSmithKline (GSK) Biologicals FLU NG vaccine compared to the referenc... | ||
| Medical condition: Immunization against influenza in male and female subjects aged 66 years or older and 19-43 years of age. | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Completed) BE (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-002369-29 | Sponsor Protocol Number: T08 | Start Date*: 2008-08-20 |
| Sponsor Name:MSE Pharmazeutika GmbH | ||
| Full Title: Randomized, double-blind study of nanoquinone versus placebo in patients with tinnitus aurium and low baseline blood levels of Q10 | ||
| Medical condition: Patients with tinnitus aurium and low blood levels of Q10 | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: DE (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-002380-14 | Sponsor Protocol Number: P071204 | Start Date*: Information not available in EudraCT |
| Sponsor Name:ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) | ||
| Full Title: Protocole n° 2 de thérapie génique du déficit immunitaire combiné sévère lié à l’X (DISC-X1) lié à l’X (DISC-X1) à l’aide d’un vecteur rétroviral sécurisé | ||
| Medical condition: Déficit immunitaire lié à l'X | ||
| Disease: | ||
| Population Age: Newborns, Infants and toddlers, Children, Under 18 | Gender: | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2008-002381-55 | Sponsor Protocol Number: ROC-RIT-2007-02 | Start Date*: 2009-06-16 | |||||||||||
| Sponsor Name:ROCHE FARMA, S.A. | |||||||||||||
| Full Title: Evaluación de la Eficacia de Rituximab en pacientes con Artritis Reumatoide a través de la medición, por Resonancia Magnética de Mano, de los parámetros clínicos de la enfermedad. Estudio RESONAR. ... | |||||||||||||
| Medical condition: Pacientes con artritis reumatoide (AR) activa refractarios a uno o más fármacos antiTNF (definido por un DAS28>3,2). | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-016378-34 | Sponsor Protocol Number: MI-CP204 | Start Date*: 2010-06-30 | |||||||||||||||||||||
| Sponsor Name:MedImmune LLC | |||||||||||||||||||||||
| Full Title: An Open Label, Phase 1/2 Study of MEDI-551, a Humanized Monoclonal Antibody Directed Against CD19, in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies | |||||||||||||||||||||||
| Medical condition: Relapsed or refractory advanced B-cell malignancies: chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), B-cell non-Hodgkin’s lymphoma (NHL) (subtypes: follicular lymphoma (FL)... | |||||||||||||||||||||||
|
|||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
| Trial protocol: BE (Completed) FR (Completed) | |||||||||||||||||||||||
| Trial results: View results | |||||||||||||||||||||||
| EudraCT Number: 2009-011828-64 | Sponsor Protocol Number: FRS-AN2009-03-26 | Start Date*: 2009-08-03 |
| Sponsor Name:Anesthesiological dep., Hospital of Frederikssund | ||
| Full Title: Spinalanæstesi til knæartroskopi: Kan tilsætning af Lidokain til Bupivacain forkorte blokadens varighed? | ||
| Medical condition: Duration of nerve blockade after spinal anesthesia with either bupivacaine or a mixture of bupivacaine/lidocaine. | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: DK (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2009-011856-23 | Sponsor Protocol Number: ERNPL | Start Date*: 2009-09-16 | |||||||||||
| Sponsor Name:OSPEDALE POLICLINICO S. MATTEO | |||||||||||||
| Full Title: Evaluation of acute postsurgery pain management in patients who undergo inguen hernia surgery | |||||||||||||
| Medical condition: Acute post surgery pain in patients who undergo inguen hernia surgery | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: IT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2009-011382-80 | Sponsor Protocol Number: | Start Date*: 2009-06-22 |
| Sponsor Name:Nottingham University Hospital | ||
| Full Title: Intravenous Iron: biomarkers and treatment strategies in anaemic Colorectal cancer patients. | ||
| Medical condition: Anaemia (specifically related to surgical pathology) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: GB (Completed) | ||
| Trial results: View results | ||
| EudraCT Number: 2008-002681-63 | Sponsor Protocol Number: 2007CV04 | Start Date*: 2008-08-28 | |||||||||||
| Sponsor Name:Research and Innovation Services, University of Dundee | |||||||||||||
| Full Title: DOES VITAMIN D REDUCE BLOOD PRESSURE AND LV MASS IN RESISTANT HYPERTENSIVE PATIENTS WITH VITAMIN D INSUFFICIENCY? | |||||||||||||
| Medical condition: Resistant Hypertension | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-002689-68 | Sponsor Protocol Number: NL.23273.08 | Start Date*: 2009-03-10 | |||||||||||
| Sponsor Name:Isala Klinieken, location Sophia | |||||||||||||
| Full Title: Cryo-thawed embryo transfer: natural versus artificial cycle. A non inferiority trial. | |||||||||||||
| Medical condition: Subfertility in need of IVF and IVF-ICSI treatment. | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: NL (Ongoing) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2010-022520-73 | Sponsor Protocol Number: CT/10.15 | Start Date*: 2011-07-12 |
| Sponsor Name:Hellenic Oncology Research Group | ||
| Full Title: Phase II, open-label non-randomized trial to investigate the efficacy of Bevacizumab in combination with dose dense sequential chemotherapy in the neo-adjuvant setting for HER2 negative breast canc... | ||
| Medical condition: Early breast cancer (primary operable HER2-negative breast cancer) | ||
| Disease: | ||
| Population Age: | Gender: Female | |
| Trial protocol: GR (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2010-022538-10 | Sponsor Protocol Number: 112688 | Start Date*: 2011-04-05 | |||||||||||
| Sponsor Name:GlaxoSmithKline Biologicals | |||||||||||||
| Full Title: An open, phase IV, multicentre study to assess the long-term persistence of antibodies against hepatitis B and the immune response to a hepatitis B (Engerix-B™ Kinder) vaccine challenge in children... | |||||||||||||
| Medical condition: Antibody persistence and hepatitis B vaccine challenge in children aged 7–8 years, previously primed and boosted with 4 doses of GSK Biologicals’ DTPa-HBV-IPV/Hib vaccine (Infanrix hexa) as part of... | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2010-022558-18 | Sponsor Protocol Number: 2010-022558-18 | Start Date*: 2010-10-11 | ||||||||||||||||||||||||||
| Sponsor Name:AZIENDA OSPEDALIERA DI PADOVA | ||||||||||||||||||||||||||||
| Full Title: A pilot trial with clenbuterol in spinal and bulbar muscular atrophy (SBMA). | ||||||||||||||||||||||||||||
| Medical condition: spinal and bulbar muscular atrophy (SBMA) | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| Population Age: Adults, Elderly | Gender: Male | |||||||||||||||||||||||||||
| Trial protocol: IT (Ongoing) | ||||||||||||||||||||||||||||
| Trial results: (No results available) | ||||||||||||||||||||||||||||
| EudraCT Number: 2010-018315-15 | Sponsor Protocol Number: D589GC00001 | Start Date*: 2010-06-09 | |||||||||||
| Sponsor Name:AstraZeneca AB | |||||||||||||
| Full Title: A Phase 2, double-blind, randomized, parallel-group, placebo-controlled, multicenter study, comparing budesonide pMDI 160 μg bid with placebo, a 6-week efficacy and safety study in children aged 6 ... | |||||||||||||
| Medical condition: Asthma | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: SK (Prematurely Ended) LV (Completed) HU (Completed) PL (Completed) BG (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2006-004647-37 | Sponsor Protocol Number: G0373 | Start Date*: 2006-11-06 | |||||||||||
| Sponsor Name:Bangor University | |||||||||||||
| Full Title: Folate Augmentation of Treatment – Evaluation of Depression: a randomised controlled trial | |||||||||||||
| Medical condition: Individuals with moderate to severe depression according to ICD-10 criteria. | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2008-004858-33 | Sponsor Protocol Number: Version 2.0 (03Nov2010) | Start Date*: 2009-01-09 | |||||||||||
| Sponsor Name:University College London | |||||||||||||
| Full Title: Open label pilot study to treat women with chronic urinary retention or voiding dysfunction due to a primary disorder of sphincter relaxation (Fowler’s syndrome) with outpatient urethral sphincter ... | |||||||||||||
| Medical condition: Primary abnormality of the urethral sphincter or Fowlers Syndrome | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Female | ||||||||||||
| Trial protocol: GB (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.